Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Arthritis Research & Therapy|February 27, 2013
To target or not to target APRIL in systemic lupus erythematosus: that is the question!Jacques Morel, Michael HahneEMBO Reports|October 24, 2018
Mixed signals from the cell's antennae: primary cilia in cancerThibaut Eguether, Michael HahneJournal of Cellular Physiology|August 30, 2008
"APRIL hath put a spring of youth in everything": Relevance of APRIL for survivalFiona C Kimberley, Michael Hahne, Jan Paul MedemaResults and Problems in Cell Differentiation|January 15, 2009
APRIL in B-cell malignancies and autoimmunityFiona C Kimberley, Jan Paul Medema, Michael HahneCytokine|May 9, 2013
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritisRachel Audo, Bernard Combe, Michael Hahne, et al.The Journal of Biological Chemistry|February 3, 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/AktJacques Morel, Rachel Audo, Michael Hahne, et al.Current Molecular Medicine|December 17, 2008
The expanding role of APRIL in cancer and immunityLourdes Planelles, Jan Paul Medema, Michael Hahne, et al.Cytokine|November 30, 2010
Lymphotoxin α stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblastsFlavia Calmon-Hamaty, Bernard Combe, Michael Hahne, et al.Arthritis Research & Therapy|August 25, 2011
Lymphotoxin α revisited: general features and implications in rheumatoid arthritisFlavia Calmon-Hamaty, Bernard Combe, Michael Hahne, et al.Immunology and Cell Biology|March 26, 2008
Thymus-independent class switch recombination is affected by APRILGijs Hardenberg, Liesbeth van Bostelen, Michael Hahne, et al.Pageof 6